Price$0.80-0.15 (-16.21%)
2026-01-212026-04-24
News · 26 weeks38-100%
2025-11-022026-04-26
Mix1490d
- SEC Filings7(50%)
- Market5(36%)
- Insider1(7%)
- Offering1(7%)
Latest news
25 items- SECSEC Form 10-K filed by Tenon Medical Inc.10-K - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Results~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half Momentum ~~ Record Full Year 2025 Gross Profit of $2.4 Million, a 38% Increase Compared to Prior Year ~~ Secured FDA 510(k) Clearance For its Next-Generation SImmetry®+ SI Joint Fusion System ~~ Completed Initial SImmetry®+ Procedures at Centers of Excellence, Advancing Commercial Rollout and Supporting Early Surgeon Adoption ~LOS GATOS, CA / ACCESS Newswire / March 19, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company redefining care for patients sufferin
- SECAmendment: SEC Form D/A filed by Tenon Medical Inc.D/A - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form D filed by Tenon Medical Inc.D - Tenon Medical, Inc. (0001560293) (Filer)
- PRWallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 MillionJERSEY CITY, N.J., March 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), private placement of senior convertible promissory notes with several institutional and high net worth investors for aggregate gross proceeds of $4.3 million before deducting fees of the placement agent. The 20% original issue discount notes have an aggregate principal amount of $4.3 million with a maturity date of September 11, 2026 and are con
- NEWSTenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 MillionLOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the closing of a private placement of senior convertible promissory notes with several institutional and high net worth investors for aggregate gross proceeds of $4.3 million before deducting fees of the placement agent.The 20% original issue discount notes have an aggregate principal amount of $4.3 million with a maturity date of September 11, 2026 and are convertible, following the six month anniversary of the issuance date, into shares of the Company's common stock at a conve
- INSIDERChief Financial Officer Williamson Kevin converted options into 1,041 shares, increasing direct ownership by 2% to 43,593 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- SECTenon Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent ExpansionExpanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth StrategyLOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's growing patent portfolio and build upon the (10) ten patents issued in 2025, including (5) five issued b
- SECSEC Form S-8 filed by Tenon Medical Inc.S-8 - Tenon Medical, Inc. (0001560293) (Filer)
- SECTenon Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected RevenuesFourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over yearLOS GATOS, CA / ACCESS Newswire / February 5, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will
- NEWSTenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year.Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year.LOS GATOS, CA / ACCESS Newswire / January 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today issued a letter to shareholders from Steve Foster, President and Chief Executive Officer.Dear Fellow Shareholders,2025 was marked by strong commercial execution as we advanced innovation and expanded our differentiated solutions in the marketplace. We delivered both sequential and year over year revenue growt
- INSIDERCEO and President Foster Steven M converted options into 140,936 shares, increasing direct ownership by 616% to 163,814 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Hochschuler Stephen converted options into 10,732 shares and covered exercise/tax liability with 3,327 shares, increasing direct ownership by 1,389% to 7,938 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Weigle Robert K converted options into 10,732 shares and covered exercise/tax liability with 3,413 shares, increasing direct ownership by 3,141% to 7,552 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERChief Financial Officer Williamson Kevin converted options into 58,987 shares and covered exercise/tax liability with 18,518 shares, increasing direct ownership by 1,943% to 42,552 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERChief Technology Officer Ginn Richard converted options into 126,577 shares and covered exercise/tax liability with 47,426 shares, increasing direct ownership by 1,229% to 85,589 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Jacques Kristine M converted options into 10,729 shares (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Howard Ivan converted options into 10,732 shares and covered exercise/tax liability with 3,327 shares, increasing direct ownership by 701% to 8,462 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Ferrari Richard converted options into 64,478 shares, increasing direct ownership by 1,026% to 70,764 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Howard Ivan converted options into 156 shares, increasing direct ownership by 17% to 1,057 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERDirector Weigle Robert K converted options into 156 shares, increasing direct ownership by 203% to 233 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- INSIDERSEC Form 4 filed by Director Jacques Kristine M4 - Tenon Medical, Inc. (0001560293) (Issuer)